HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping Jiang Selected Research

PEGPH20

1/2018HALO 202: Randomized Phase II Study of PEGPH20 Plus Nab-Paclitaxel/Gemcitabine Versus Nab-Paclitaxel/Gemcitabine in Patients With Untreated, Metastatic Pancreatic Ductal Adenocarcinoma.
1/2018Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours.
1/2016Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer.
2/2015Tumor-associated hyaluronan limits efficacy of monoclonal antibody therapy.
1/2014Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment.
4/2012Effective targeting of the tumor microenvironment for cancer therapy.
11/2010Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ping Jiang Research Topics

Disease

98Neoplasms (Cancer)
06/2022 - 03/2002
57Infections
11/2022 - 10/2003
20Neoplasm Metastasis (Metastasis)
01/2021 - 01/2003
19Inflammation (Inflammations)
01/2022 - 06/2007
12Virus Diseases (Viral Diseases)
02/2021 - 07/2006
11Carcinoma (Carcinomatosis)
02/2021 - 07/2003
10Prostatic Neoplasms (Prostate Cancer)
05/2018 - 07/2003
10Breast Neoplasms (Breast Cancer)
04/2016 - 01/2002
9Pain (Aches)
01/2022 - 07/2013
9Thrombosis (Thrombus)
10/2020 - 02/2014
9Fibrosarcoma
10/2013 - 01/2003
8Rheumatoid Arthritis
01/2022 - 10/2016
8Asthma (Bronchial Asthma)
01/2022 - 12/2014
8Lung Neoplasms (Lung Cancer)
10/2021 - 02/2004
8Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 09/2005
7Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 04/2016
7Obesity
01/2022 - 04/2010
7Hypertension (High Blood Pressure)
04/2021 - 02/2011
7Wounds and Injuries (Trauma)
01/2021 - 11/2011
7Myocardial Infarction
12/2020 - 10/2006
7Stomach Neoplasms (Stomach Cancer)
01/2019 - 09/2011
6Colorectal Neoplasms (Colorectal Cancer)
06/2022 - 11/2014
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 04/2012
6Fibrosis (Cirrhosis)
01/2022 - 08/2015
6Carcinogenesis
01/2021 - 01/2013
6Alzheimer Disease (Alzheimer's Disease)
01/2021 - 08/2008
6Stroke (Strokes)
01/2021 - 01/2018
6Hepatocellular Carcinoma (Hepatoma)
01/2020 - 08/2011
6Insulin Resistance
01/2017 - 04/2010
6Body Weight (Weight, Body)
01/2017 - 10/2006
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2016 - 04/2005
5Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2017
5Lymphatic Metastasis
05/2020 - 09/2015
5Diabetes Mellitus
04/2019 - 07/2014
5Melanoma (Melanoma, Malignant)
08/2012 - 03/2005
5Dyslipidemias (Dyslipidemia)
01/2012 - 01/2009
4Liver Diseases (Liver Disease)
01/2022 - 03/2007
4Tuberculosis (Tuberculoses)
01/2021 - 04/2002
4Schizophrenia (Dementia Praecox)
01/2021 - 06/2015
4Death (Near-Death Experience)
12/2020 - 06/2018
4Acute Coronary Syndrome
10/2020 - 11/2017
4Porcine Reproductive and Respiratory Syndrome (PRRS)
11/2019 - 11/2007
4Hypoxia (Hypoxemia)
09/2019 - 08/2012
4Adenocarcinoma
01/2018 - 01/2013
4Endometriosis
11/2014 - 07/2013

Drug/Important Bio-Agent (IBA)

51Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2002
24Green Fluorescent ProteinsIBA
05/2015 - 01/2002
23Red Fluorescent ProteinIBA
05/2015 - 01/2003
22VaccinesIBA
11/2022 - 10/2003
18Pharmaceutical PreparationsIBA
01/2022 - 01/2002
14Histones (Histone)IBA
01/2021 - 06/2004
13Biomarkers (Surrogate Marker)IBA
06/2022 - 07/2013
13Antiviral Agents (Antivirals)IBA
05/2021 - 03/2008
13Messenger RNA (mRNA)IBA
01/2021 - 12/2003
12Biological ProductsIBA
03/2022 - 04/2002
10RNA (Ribonucleic Acid)IBA
04/2022 - 03/2008
10EnzymesIBA
09/2021 - 11/2010
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 08/2007
10Hyaluronic Acid (Hyaluronan)IBA
01/2018 - 11/2010
9Small Interfering RNA (siRNA)IBA
01/2021 - 07/2006
8LipidsIBA
01/2017 - 09/2005
7MicroRNAs (MicroRNA)IBA
01/2022 - 01/2018
7Iodine-125IBA
11/2021 - 07/2010
7Triglycerides (Triacylglycerol)IBA
09/2021 - 01/2009
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2021 - 12/2009
7AntioxidantsIBA
04/2021 - 03/2007
7DNA (Deoxyribonucleic Acid)IBA
04/2021 - 11/2003
7PEGPH20IBA
01/2018 - 11/2010
6CytokinesIBA
01/2022 - 08/2010
6Therapeutic UsesIBA
04/2021 - 08/2005
6Phosphotransferases (Kinase)IBA
11/2020 - 04/2005
6Niacin (Nicotinic Acid)FDA LinkGeneric
01/2012 - 01/2009
5CholesterolIBA
09/2021 - 04/2010
5Transcription Factors (Transcription Factor)IBA
01/2021 - 11/2014
5Glucose (Dextrose)FDA LinkGeneric
01/2017 - 04/2010
5Insulin (Novolin)FDA Link
01/2017 - 04/2010
4AntibodiesIBA
08/2022 - 11/2011
4VimentinIBA
01/2022 - 11/2014
4InterferonsIBA
09/2021 - 01/2016
4ImmunosorbentsIBA
08/2021 - 08/2012
4Long Noncoding RNAIBA
12/2020 - 01/2020
4omega-Chloroacetophenone (Mace)IBA
12/2020 - 06/2018
4GemcitabineFDA Link
10/2020 - 01/2004
4protease-activated receptor 4IBA
11/2018 - 09/2011
4LeptinIBA
03/2018 - 04/2010
4Proteinase-Activated ReceptorsIBA
01/2018 - 01/2013
4Blood Glucose (Blood Sugar)IBA
01/2017 - 02/2011
4Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2016 - 09/2012
4Hormones (Hormone)IBA
08/2014 - 08/2002

Therapy/Procedure

42Therapeutics
10/2022 - 04/2002
24Radiotherapy
06/2022 - 11/2010
15Percutaneous Coronary Intervention
01/2022 - 11/2017
14Brachytherapy
11/2021 - 12/2014
10Drug Therapy (Chemotherapy)
03/2021 - 01/2008
10Stents
10/2020 - 02/2014
9Salvage Therapy
03/2021 - 03/2012
5Length of Stay
04/2021 - 02/2015
5Aftercare (After-Treatment)
05/2018 - 01/2002
4Immunotherapy
07/2021 - 08/2012
4Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2021 - 11/2015